© dkfz.de

A major branch of health economics is concerned with the study of how scarce healthcare resources are allocated among competing health care programs and, by implication, among different groups in society. In health economics, tools such as cost-effectiveness analysis (CEA) are often used to inform decision makers. Conventionally, CEA is designed to help achieve the maximum potential health benefits given a resource constraint or "scarcity". Results of conventional CEAs may, however, contradict prevailing social norms and preferences. The Summer School addresses the underlying issues by introducing and reviewing concepts and methods divided into two modules: basic and advanced. Taken together, these two modules offer a comprehensive overview of principles and methods, but they may also be taken separately.

The Basic Module of the Summer School introduces basic concepts of health economics and addresses practical issues faced by health care decision makers responsible for allocating scarce resources. One of the main objectives of the Summer School is to bring together different stakeholders, such as payers, physicians, policy makers, representatives from the industry and academy, and others who are involved in different segments of the health care system. The Basic Module was created with the objective of giving those without previous knowledge of health economics the tools to comprehend key issues. These issues include potential implications for cost value assessments of orphan medicinal products and advanced therapy medicinal products (ATMPs).  

The Advanced Module includes an in-depth review of the strengths and limitations of the conventional approaches, where both participants and speakers with different backgrounds are able to discuss implications, potential solutions, and ways forward. Every year a different topic that affects the way decisions are made in the healthcare sector is discussed, and a group of recognized speakers from the academy and the industry is invited to present and discuss current theory and practice, including examples of the most up-to-date problems faced by the healthcare sector.

Health Economics Summer School 2020 - HESS 2020

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) Division of Health Economics is delighted to invite you to the Heidelberg Health Economics Summer School 2020. It will take place the third week of September in the Studio Villa Bosch in Heidelberg.

For further details please refer to HESS-2020.

© dkfz.de

International Speakers

Prof. Amiram Gafni, Centre for Health Economics and Policy Analysis, McMaster University, Hamilton, ON, Canada

Josie Godfrey, JG Zebra Consulting, London, UK (Former Associate Director, Highly Specialised Technologies, National Institute for Health and Care Excellence [NICE], London, UK)

Dr. Diego Hernández Carreno, Division of Health Economics, DKFZ, Heidelberg, Germany

Dr. Karla Hernández-Villafuerte, Division of Health Economics, DKFZ, Heidelberg, Germany

Prof. Søren Holm, University of Manchester, Manchester, UK & University of Oslo, Oslo, Norway

Dr. Mohit Jain, Vice President, Market Access EUMEA at BioMarin, London, UK

Prof. Frank Lichtenberg, Columbia University Graduate School of Business, New York, NY, USA

Prof. Jorge Mestre-Ferrandiz, Universidad Carlos III, Madrid, Spain

Prof. Ulf Persson, The Swedish Institute for Health Economics, Lund, Sweden

Prof. Maarten Postma, University of Groningen, Groningen, The Netherlands

Prof. Gérard de Pouvourville, ESSEC - École Supérieure des Sciences Économiques et Commerciale, Paris, France

Prof. Jeffrey Richardson, Monash University, Melbourne, Vic, Australia

Prof. James Robinson, University of California at the Berkeley Center for Health Technology, Berkeley, CA, USA

Prof. Michael Schlander, DKFZ & University of Heidelberg, Heidelberg, Germany

Prof. Adrian Towse, The Office of Health Economics, London, UK

For additional information, please do not hesitate to contact us: HESS@dkfz-heidelberg.de

Health Economics Summer School 2019 - HESS 2019

The German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) Division of Health Economics in collaboration with Hochschule Heilbronn and University of Heidelberg organized the Heidelberg Health Economics Summer School 2019. It was held at the Studio Villa Bosch in Heidelberg during the first week of July 2019.

In the Summer School 2019 the need for broader or alternative concepts that capture citizens’ social norms and preferences and the search for alternatives were the focus of the discussion. Potential implications for cost value assessments of orphan medicinal products, gene and CAR-T cell therapies, and “personalized medicine” were addressed by a group of international experts in Health Technology Assessment, evidence-based medicine, health economics, and medical ethics.

International speakers

Prof. Silvio Garattini, IRCCS – Istituto di Richerche Farmacologiche Mario Negri, Milan, Italy

Dr. Ansgar Hebborn, Head European Access Policy Affairs, F. Hoffmann-La Roche AG, Switzerland

Prof. Søren Holm, University of Manchester, UK & University of Oslo, Norway

Dr. Mohit Jain, London, UK

Prof. Maarten Postma, University of Groningen, the Netherlands

Prof. Gérard de Pouvourville, ESSEC - École Supérieure des Sciences Économiques et Commerciale, Paris, France

Prof. Jeffrey Richardson, Centre for Health Economics, Monash University, Melbourne, Australia

Prof. Wendelin Schramm, University of Applied Sciences Heilbronn, Germany

Prof. Michael Schlander, DKFZ & University of Heidelberg, Heidelberg, Germany

Prof. Oriol de Sola-Morales, IISPV & Universitat Internacional Catalunya (UIC), Spain

Prof. Adrian Towse, The Office of Health Economics, London, UK

  

We invite you to take a look of some of the photos from the HESS 2019

For more information, here you can find HESS 2019 agenda.

to top
powered by webEdition CMS